Results 161 to 170 of about 5,456,142 (288)

Phosphatidylethanol in the Management of Steatotic Liver Disease

open access: yes
Baggrund: Steatotisk leversygdom (SLD) dækker over et spektrum af tilstande med ophobning af lipider i hepatocytter, herunder metabolisk dysfunktion-associeret steatotisk leversygdom (MASLD), alkoholrelateret leversygdom (ALD) og den nyligt definerede fænotype metabolisk og alkohol-relateret leversygdom (MetALD).
openaire   +2 more sources

The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta‐Analysis

open access: yesAndrology, EarlyView.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) and male hypogonadism are increasingly prevalent, metabolically interrelated conditions. Testosterone (T) deficiency has been implicated in hepatic lipid dysregulation, insulin resistance, and visceral adiposity, whereas MASLD may impair the hypothalamic–pituitary ...
Giorgia Spaggiari   +9 more
wiley   +1 more source

Re‐Evaluating the Comparison of Four Different Ultrasound Elastography Techniques for Diagnosing Advanced Fibrosis

open access: yes
Portal Hypertension &Cirrhosis, EarlyView.
Zain Ul Abedeen   +3 more
wiley   +1 more source

Impact of Single Viable Hepatocellular Carcinoma ≤ 3 cm on Survival After Liver Transplantation

open access: yesANZ Journal of Surgery, EarlyView.
An Australian multi‐centre cohort study shows significantly lower 5‐year HCC‐specific mortality for those with no viable disease compared to those with a single viable tumour ≤ 3 cm, on imaging prior to transplantation. A lower AFP level and complete response on mRECIST criteria also reduced risk.
Lauren C. Y. Tang   +12 more
wiley   +1 more source

When Machine Perfusion Falls Short: Identifying Risks of Liver Graft Failure After Normothermic Machine Perfusion

open access: yesArtificial Organs, EarlyView.
Analysis of 4928 normothermic machine perfusion liver transplants reveals that recipient factors, particularly MELD ≥ 35, surgical complexity, ICU status, and functional impairment are stronger predictors of graft failure than donor characteristics, emphasizing the continued importance of clinical judgment in patient selection.
Lauren E. Matevish   +9 more
wiley   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease: An Underrated and Emerging Cardiovascular Risk Factor. [PDF]

open access: yesAnatol J Cardiol
Sabouret P   +12 more
europepmc   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy